Teladoc Health Other Share Holders Equity 2014-2024 | TDOC

Teladoc Health other share holders equity from 2014 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Teladoc Health Annual Other Share Holders Equity
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
Teladoc Health Quarterly Other Share Holders Equity
(Millions of US $)
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $1.572B $2.602B
Teladoc Health, Inc. provides virtual access to high-quality care and expertise with a portfolio of services and solutions, covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company combines the latest in data and analytics with an award-winning user experience through a highly flexible technology platform. The company provides access to healthcare through its portfolio of five consumer brands 24 hours a day, seven days a week and 365 days a year. Its solutions are delivered with an approximate median response time of less than ten minutes in the United States for general medical inquiries from the time a member requests a general medical telehealth visit to the time they consult with a Teladoc Health network provider.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.755B 15.21
Cencora (COR) United States $44.643B 17.06
ICON (ICLR) Ireland $24.824B 22.31
DiDi Global (DIDIY) China $19.247B 0.00
Avantor (AVTR) United States $18.832B 28.56
Natera (NTRA) United States $15.724B 0.00
Revvity (RVTY) United States $15.600B 27.32
Viatris (VTRS) United States $14.203B 4.33
CochLear (CHEOY) Australia $12.744B 0.00
Solventum (SOLV) United States $12.494B 0.00
Medpace Holdings (MEDP) United States $11.445B 34.73
Charles River Laboratories (CRL) United States $10.823B 20.45
Sonic Healthcare (SKHHY) Australia $8.820B 0.00
Doximity (DOCS) United States $7.543B 47.80
Bausch + Lomb (BLCO) Canada $7.041B 30.30
HealthEquity (HQY) United States $6.863B 37.25
PACS (PACS) United States $6.338B 0.00
Organon (OGN) United States $5.196B 5.28
Life Times (LTH) United States $4.995B 41.75
Sotera Health (SHC) United States $4.687B 23.64
Surgery Partners (SGRY) United States $4.212B 46.66
Concentras Parent (CON) United States $2.895B 0.00
GoodRx Holdings (GDRX) United States $2.687B 101.14
BrightSpring Health Services (BTSG) United States $2.577B 0.00
Ardent Health Partners (ARDT) United States $2.565B 0.00
Alignment Healthcare (ALHC) United States $2.179B 0.00
Premier (PINC) United States $2.039B 9.17
Ryman Healthcare (RYHTY) New Zealand $1.921B 0.00
AMN Healthcare Services Inc (AMN) United States $1.745B 8.77
Agilon Health (AGL) United States $1.592B 0.00
CareDx (CDNA) United States $1.576B 0.00
Progyny (PGNY) United States $1.486B 26.13
Establishment Labs Holdings (ESTA) $1.228B 0.00
GeneDx Holdings (WGS) United States $1.095B 0.00
Pediatrix Medical (MD) United States $0.933B 10.16
QDM (QDMI) Hong Kong, SAR China $0.933B 24.43
Embecta (EMBC) United States $0.907B 6.04
InnovAge Holding (INNV) United States $0.827B 0.00
Auna S.A (AUNA) Luxembourg $0.551B 0.00
Sharecare (SHCR) United States $0.524B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.506B 0.00
Enhabit (EHAB) United States $0.414B 35.83
Sonida Senior Living (SNDA) United States $0.374B 0.00
DocGo (DCGO) United States $0.368B 13.85
Sera Prognostics (SERA) United States $0.260B 0.00
Biodesix (BDSX) United States $0.258B 0.00
LifeMD (LFMD) United States $0.227B 0.00
Ascend Wellness Holdings (AAWH) United States $0.208B 0.00
Beauty Health (SKIN) United States $0.190B 0.00
ModivCare (MODV) United States $0.181B 5.75
MultiPlan (MPLN) United States $0.137B 0.00
Nutex Health (NUTX) United States $0.128B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.083B 0.00
So-Young (SY) China $0.076B 18.40
NeueHealth (NEUE) United States $0.045B 1.78
Co-Diagnostics (CODX) United States $0.041B 0.00
Singular Genomics Systems (OMIC) United States $0.040B 0.00
OncoCyte (OCX) United States $0.040B 0.00
IceCure Medical (ICCM) Israel $0.030B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Pheton Holdings (PTHL) China $0.028B 0.00
Oncology Institute (TOI) United States $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.021B 0.00
TRxADE HEALTH (MEDS) United States $0.011B 0.00
XWELL (XWEL) United States $0.010B 0.00
KindlyMD (KDLY) $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00